• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.45% Nasdaq Down1.03%

    Capstone Therapeutics Corp. (CAPS)

    -Other OTC
    0.22 Up 0.00(0.46%) Jan 30, 11:46AM EST
    Add to Portfolio
    ProfileGet Profile for:
    Capstone Therapeutics Corp.
    1275 West Washington Street
    Suite 104
    Tempe, AZ 85281
    United States - Map
    Phone: 602-286-5520
    Website: http://www.capstonethx.com

    Index Membership:N/A
    Full Time Employees:2

    Business Summary 

    Capstone Therapeutics Corp., a biotechnology company, focuses on developing a pipeline of peptides and other molecules for helping patients with under-served medical conditions. It develops AZX100, a novel synthetic 24-amino acid peptide that has completed Phase 2 study for dermal scarring, and is in pre-clinical studies for Pulmonary Fibrosis and Peridural Fibrosis; and Apo E mimetic peptide molecule AEM-28 and its analogs that play an important role in lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Capstone Therapeutics Corp.

    Key Executives 
    Mr. John M. Holliman III, 61
    Exec. Chairman and Chief Exec. Officer
    Mr. Leslie M. Taeger , 64
    Chief Financial Officer, Principal Accounting Officer and Sr. VP
    Dr. Randolph C. Steer M.D., Ph.D., 65
    Dr. William M. Wardell M.D., Ph.D., 76
    Head of Clinical & Regulatory Review Board
    Ms. Karen Struck ,
    Investor Relations Professional
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders